Bahrain Registration

Product Registration in Bahrain

Bahrain is regulated by the National Health Regulatory Authority (NHRA) — and it is structurally different from its neighbours in a way that matters.

NHRA is an independent regulatory authority established under Law No. 38 of 2009, not a department inside the Ministry of Health. Within it, the Pharmacy and Pharmaceutical Products Regulation section covers the quality, safety and efficacy of medicines, health products and alternative and complementary medicines.

Bahrain splits supplements between two regulators

This is the key Bahrain nuance, and getting it wrong costs months.

• Health products — herbal, vitamin and mineral products in pharmaceutical dosage forms — are regulated by NHRA, as pharmaceutical products. A parallel route exists for alternative and complementary medicines.
• “Special food” and food supplements — vitamins and minerals within specified maximum levels, infant foods, weight-control products, sports supplements, energy drinks and health-claim foods — are licensed by the Nutrition Section of the Public Health Directorate at the Ministry of Health, assessed against GCC and GSO standards.

NHRA does not regulate food. Which side of the line your product falls on depends on dose, dosage form and claim. This is a genuine scoping question to settle before any dossier work starts, not a formality.

The hard gate: one year of prior marketing

For health products, Bahrain requires a legalised free sale certificate or product licence from the country of origin, and evidence of marketing in the country of origin for at least one year before it will accept a new registration. For alternative and complementary medicines, a legalised free sale certificate stating the marketing date is required, together with documentation of worldwide registration and marketing status with specific dates.

The consequence is blunt: a newly developed Canadian supplement cannot be filed in Bahrain until it has been licensed and actually sold in Canada, or another origin market, for a year.

This belongs in your launch plan as a sequencing constraint. It also means Bahrain is rarely the right first market for a new product — but it is a straightforward one for a product with established domestic sales history.

The equivalent current rule for prescription medicines could not be confirmed from an accessible official source, and we verify it per project rather than assume.

What Bahrain expects

• A licensed local establishment — a valid health product shop licence, or a pharmacy licence with the relevant activity, depending on the route. A signed cover letter from the local agent and the company is required.
• Full eCTD for medicines. Health products use a document-checklist submission rather than a full CTD.
• A valid, legalised GMP certificate or manufacturing licence with at least three months’ remaining validity. Certificates close to expiry are a documented cause of rejection — check dates before you submit, not after.
• Bilingual mock-ups of labels and package leaflet. On the food side, Arabic is unambiguously mandatory under GSO 9.
• Mandatory declarations covering alcohol content, pork-free status, and heavy metals and pesticides for herbal products; for alternative and complementary medicines, add certificates of analysis for actives and finished product including pesticide testing, plus GMO-free, hormone-free and heavy-metal-free declarations.

How Raised Pharma helps

• Regulator scoping — determining whether your product goes to NHRA or to the Ministry of Health nutrition route.
• Launch sequencing — planning around the one-year origin-market requirement rather than discovering it late.
• Formulation and sourcing to satisfy alcohol, porcine, heavy-metal and pesticide declarations.
• eCTD dossier preparation and health product document sets.
• GMP documentation with validity tracking.
• Bilingual labelling and claims review.

Talk to us about Bahrain

Email: info@raisedpharma.com    Phone: +1 (716)-777-4800

Request a consultation   See all GCC markets

Important: General information, not regulatory or legal advice. NHRA publishes detailed licensing guidelines that should be obtained directly; some requirements described here are drawn from Bahrain’s national service portal rather than NHRA’s own guideline documents. Classification, dossier content, labelling and prior-marketing requirements must be confirmed with NHRA and reviewed by a qualified regulatory professional before filing. Last reviewed August 2026.